1. Home
  2. CHD vs UTHR Comparison

CHD vs UTHR Comparison

Compare CHD & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Church & Dwight Company Inc.

CHD

Church & Dwight Company Inc.

HOLD

Current Price

$99.07

Market Cap

23.4B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$559.46

Market Cap

25.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHD
UTHR
Founded
1846
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4B
25.1B
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
CHD
UTHR
Price
$99.07
$559.46
Analyst Decision
Buy
Buy
Analyst Count
17
14
Target Price
$102.18
$567.57
AVG Volume (30 Days)
1.7M
478.3K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
1.28%
N/A
EPS Growth
27.43
13.07
EPS
0.91
5.82
Revenue
$6,203,200,000.00
$1,483,300,000.00
Revenue This Year
$0.25
$6.39
Revenue Next Year
$3.65
$14.18
P/E Ratio
$108.78
$96.76
Revenue Growth
1.57
2.38
52 Week Low
$81.33
$272.18
52 Week High
$106.04
$609.35

Technical Indicators

Market Signals
Indicator
CHD
UTHR
Relative Strength Index (RSI) 55.73 56.23
Support Level $91.85 $533.78
Resistance Level $100.48 $580.39
Average True Range (ATR) 2.17 12.44
MACD 0.07 2.14
Stochastic Oscillator 78.83 94.83

Price Performance

Historical Comparison
CHD
UTHR

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Share on Social Networks: